Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

TriHealth

Status and phase: Withdrawn; Phase 4

Conditions: Pain Management After Breast Biopsy

Treatments: Drug: Lidocaine alone; Drug: Lidocaine Ropivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02085239

13027-13-033

Details and patient eligibility

About

This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.

Full description

The purpose of this study is to evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast. One group of patients will receive lidocaine alone for local anesthesia. A second group of patients will similarly receive lidocaine prior to tissue sampling, followed by infiltration of the biopsy area with ropivacaine.

Our hypothesis is that patients who receive a long acting anesthetic (ropivacaine) along with the popular short acting anesthetic (lidocaine), will be pain free after the breast biopsy procedure for a longer period of time than the patients who only receive lidocaine (the short acting anesthetic). This will lessen the emotional and physical trauma associated with the procedure and give patients a better experience thereby improving patient care.

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with breast lesions recommended for biopsy by physician

Exclusion criteria

• Patients with breast lesions not recommended for biopsy
• Patients with allergic reactions to lidocaine, ropivacaine, or related anesthetics

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Lidocaine alone

Active Comparator group

Description:

Lidocaine: 8-10 ml of Lidocaine by subcutaneous injection

Treatment:

Drug: Lidocaine alone

Lidocaine Ropivacaine

Experimental group

Description:

Lidocaine Ropivacaine * 8-10 ml of Lidocaine given by subcutaneous injection * 8-10 ml of Ropivacaine given by subcutaneous injection

Treatment:

Drug: Lidocaine Ropivacaine